ReviewACS polymers Au2026
Recent Advances on Starch-Based Biomaterials: A Review.
Review in ACS polymers Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Starch's versatility inspires biomaterials for biomedical uses, customized through modifications, blending, or substituents. Diligent efforts have been dedicated to the development of starch-based biomaterials, leveraging the material's inherent biocompatibility and biodegradability, while aligning with environmentally sustainable considerations. While promising, most studies lack in vivo data and scalability assessments. In many cases, the reported advances are restricted to in vitro evaluations with limited information on long-term performance, clinical translation, and large-scale manufacturing feasibility in both economic and operational terms. This review furnishes an up-to-date synthesis of information available in the literature concerning recent breakthroughs in utilizing starch as a biomaterial, primarily focusing on advancements in areas such as wound dressings, drug delivery systems, the creation of scaffolds for regenerative medicine, and applications in tissue engineering. Advances have been made, with biomaterials presenting adequate biodegradability rates, active functions, good biocompatibility, and mechanical properties. However, it is noted that most research has not yet reached in vivo evaluations and lacks notions of large-scale production, in both economic and operational terms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.